AMN Healthcare Services Inc: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 25, 2015 and accepted by EDGAR at Feb 24, 2015, 17:52 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $279.6m | us-gaap:Revenues |
| Revenue | 12 months2014-01-01 to 2014-12-31 | $1.04bn | us-gaap:Revenues |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $719.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $84.7m | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $316.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $232.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $67.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $9.2m | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $25.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $9.9m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | $33.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $0.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.21 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $0.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 48,086,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $27.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $19.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $13.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $282.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $681.9m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $178.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $425.3m | us-gaap:Liabilities |
| Long-term debt | At period end2014-12-31 | $144.4m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2014-12-31 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-12-31 | $256.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-15-000003. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.